INTRODUCTION
High-mobility group box 1 (HMGB1) is a highly conserved, ubiquitous protein present in the nuclei of various types of cells 1 . HMGB1 has been identified as a nuclear DNA-binding protein, which participates in maintaining nucleosome structure, regulating gene transcription, and modulating the activity of steroid hormone receptors 2, 3 . This protein is essential for survival, since HMGB1-deficient mice die due to hypoglycemia within 24 hrs after birth 4 . On the other hand, recent studies have demonstrated that HMGB1 is secreted into the extracellular milieu from necrotic and inflammatory cells, but not apoptotic cells, and acts as a cytokine with multiple functions 5 . HMGB1 has been reported to transduce cellular signals by interacting with at least three receptors: receptor for advanced glycation end products (RAGE), Toll-like receptor (TLR)-2 and TLR-4 4 . Signaling through these receptors leads to activation of the nuclear factor-κB (NF-κB), extra-cellular signal regulated kinase and p38 mitogen activated protein kinase [6] [7] . Thus once released, HMGB1 mediates various cellular responses including cell migration, release of pro-inflammatory cytokines, tissue repair, 4 proangiogenic effects by cell proliferation, chemotaxis, migration, and sprouting of endothelial cells in vitro 6, 10 .
Based on these findings, we hypothesized that HMGB1 enhanced angiogenesis and restored cardiac function after myocardial infarction. To test this hypothesis, we generated transgenic mice with cardiac specific overexpression of HMGB1 using α-myosin heavy chain (MHC) promoter. We examined cardiac function, survival, and capillary formation after coronary artery ligation in mice. Our present results show that HMGB1 enhances capillary and arteriole formation, prevents cardiac remodeling, restores cardiac function, and improves survival after myocardial infarction in vivo.
METHODS

Generation of HMGB1 transgenic mice
All experimental procedures were performed according to the animal welfare regulations of Yamagata University School of Medicine, and the study protocol was approved by the Animal Subjects Committee of Yamagata University School of Medicine, Kagoshima, Japan) were subcloned into pGEX-5X-1 plasmids. The plasmid was digested with SpeI to generate a DNA fragment composed of the α-MHC gene promoter, HMGB1 cDNA, and a poly A tail of the human growth hormone. We microinjected the construct into the pronuclei of single-cell fertilized mouse embryos to generate transgenic mice as previously described [11] [12] [13] [14] . To detect the exogenous HMGB1 gene, genomic DNA was extracted from the tail tissues of 3-to 4-week-old pups, and polymerase chain reaction (PCR) was performed with one primer specific for the α-MHC gene promoter and another primer specific for the HMGB1 14 . Wild type littermate mice (Wt) were used as control.
Surgery of left anterior descending coronary artery ligation
Surgeon was kept unaware of the results of the genotype, and the animal surgeries were performed by the same surgeon. Induction of myocardial infarction (MI) was performed in 8-to 10-weeks-old mice as described previously 16, 17 . Briefly, mice (20 to 25 g body weight) were anesthetized by intraperitoneal injection with a mixture of ketamine (80 mg/kg) and xylazine (8 mg/kg). Animals were intubated with a 20-gauge polyethylene catheter and were ventilated with a rodent ventilator (Harvard Apparatus, Holliston, MA, USA). An incision was performed along the left sternal border, and the fourth rib was cut proximal to the sternum. The left anterior descending coronary artery was identified, and an 8-0 proline suture was passed around the artery and subsequently tied off. Successful ligation of the coronary artery was verified visually by the discoloration of the left ventricular myocardium. In sham-operated animals, the same procedure was performed except the coronary artery ligation. Finally, the heart was repositioned in the chest, and the chest wall was closed.
The animals remained in a supervised setting until fully conscious. (19, 20) .
Echocardiography and cardiac catheterization
Western blotting
Total proteins were extracted from the left ventricle with ice-cold lysis buffer as described previously [21] [22] [23] . Protein concentration of myocardial samples was carefully determined by the protein assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Equal amounts of protein were subjected to 10% SDS-PAGE electrophoresis and transferred to polyvinylidene difluoride (PVDF) membranes. To ensure equivalent protein loading and quantitative transfer efficiency of proteins, membranes were stained with Ponceau S before incubating with primary antibodies. Antibodies used in this study were a rabbit polyclonal anti-HMGB1 antibody (Shino-Test
Corporation, Sagamihara, Japan), a mouse monoclonal anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antidoby (Chemicon International, Inc., Temecula, CA, USA) and anti-β-actin antibody (SIGMA, Saint Louis, MO, USA).
Immunoreactive bands were detected by an ECL kit (Amersham Biosciences, Piscataway, NJ, USA), and cardiac HMGB1 expression was normalized to GAPDH or β-actin.
Histopathological examinations
At 4 weeks after surgery, mice were sacrificed, coronary arteries were retrogradely flushed with saline, and the heart was excised and weighed. The heart was fixed with a 2% solution of paraformaldehyde in PBS at 4 °C for 30 min, and then sequentially in 10%, 20%, 30% sucrose in PBS, respectively, for 4 hours. Then three transverse slices from the base, mid-region, and apex of the left ventricle were embedded and frozen in optimal cutting temperature compound. These three sections were stained with Masson-trichrom stain. In each left ventricular transverse section, the infarct length was calculated by measuring the endocardial and epicardial surface length delimiting the infarcted region 16, 17 . Percent infarct size was calculated as infarct length divided by the total left ventricular circumference. Some mice were analyzed for initial area at risk (AAR) by injection of Evans blue dye. Briefly, after ligation of the left anterior descending coronary artery, 0.5 ml of 1.0 % Evans blue dye was injected through the inferior vena cava to delineate the nonischemic tissue. We then excited the heart, washed with PBS and cut into three transverse slices. We determined left ventricular area and area at risk by computerized planimetry using and the data from 10 fields were averaged (24) . For double immune staining, the sections were stained with phycoerythrin conjugated anti-mouse PECAM-1 antibody (eBioscience, Inc., San Diego, CA, USA) and FITC conjugated anti-mouse αSMA antibody (SIGMA, Saint Louis, MO, USA). Fluorescence image stacks were acquired at emission wavelengths of 515 and 480 nm, respectively.
ELISA
Plasma levels of HMGB1 were measured by a commercially available ELISA kit (Shino-Test Corporation, Sagamihara, Japan) in Wt and HMGB1-Tg mice.
Statistical Analysis
All values are expressed as mean ± SE. Comparisons between Wt and HMGB1-TG mice were performed by the Mann-Whitney's U test. Effects of MI on heart weight, histological, echocardiographic, and hemodynamic findings in each animal group were analyzed by two-way ANOVA followed by multiple comparisons with a Bonferroni test. Survival curves after MI were created by the Kaplan-Meier method and compared by a log rank test. A value of P < 0.05 was considered statistically significant.
RESULTS
Generation of HMGB1-Tg mice
After microinjection and embryo implantation, HMGB1-Tg mice were successfully established, and cardiac-specific expression of transgene was confirmed by reverse transcriptase-PCR ( Figure 1A ). We could generate only one line of HMGB1-TG mouse. Protein level of HMGB1 was augmented approximately 4-fold in HMGB1-Tg mouse hearts compared to Wt as shown in Figure 1B .
Immunohistochamical staining with HMGB1 demonstrated that HMGB1 localized in the nucleus, and strong staining in the nucleus was observed in cardiomyocytes of HMGB1-Tg mice compared to Wt mice as shown in Figure 1C . However, there was no significant difference in plasma level of HMGB1 between Wt and HMGB1-Tg mice at basal condition (under the assay sensitivity respectively, < 0.2 ng/ml). No neonatal and adult deaths were observed in HMGB1-Tg mice. There were no significant differences in gravimetric data and cardiac function at basal condition between Wt and HMGB1-Tg mice as reported in Table 1 .
Changes in cardiac and plasma concentrations of HMGB1 after myocardial infarction
Cardiac HMGB1 levels were examined by Western blotting at 24 hrs after MI.
In the infarct zone, HMGB1 level decreased markedly (P < 0.01) in HMGB1-Tg mice compared to sham-operated mice (Figure 2A ). In the non-infarct zone, there was no significant change in cardiac HMGB1 level after MI.
We also measured plasma concentrations of HMGB1 before MI and at 12, 24, 48 hrs after MI by ELISA. Plasma HMGB1 levels after MI were significantly increased in both Wt and HMGB1-Tg mice. In particular, plasma HMGB1 level in HMGB1-Tg mice at 24 hrs after MI was significantly increased than that in Wt mice as shown in Figure 2B (P < 0.01). These data suggest that HMGB1 was pronouncedly released into circulation from necrotic cardiomyocytes in HMGB1-Tg mice compared to Wt mice.
Left ventricular remodeling and cardiac function after myocardial infarction
There was no significant difference in the ratio of heart weight to body weight in the sham-operated Wt and HMGB1-Tg mice (Figure 3 ). At 4 weeks after MI, the ratio of heart weight to body weight was significantly increased in Wt mice (P < 0.01).
However, increase in the ratio of heart weight to body weight after MI was significantly attenuated in HMGB1-Tg mice compared to Wt mice (P < 0.05) as demonstrated in Figure 3A .
The percent infarct size was compared between Wt and HMGB1-Tg mice. As shown in Figure 3B , the percent infarct size at 4 weeks after MI was significantly smaller in HMGB1-Tg mice than in Wt mice (P < 0.05). Initial AAR was evaluated by injection of Evans blue dye after ligation of coronary artery. However, there was no difference in size of initial AAR between Wt and HMGB1-Tg mice (58.4 + 1.4% vs.
+ 1.6%).
We examined cardiac function of Wt and HMGB1-Tg mice by echocardiography and cardiac catheterization at 4 weeks after MI. Echocardiography demonstrated that LVEDD and LVESD were significantly smaller (P < 0.01) and LVFS was significantly higher (P < 0.01) in HMGB1-Tg mice than in Wt mice at 4 weeks after MI ( Figure 4A and Table 2 ). IVS thinning was also attenuated in HMGB1-Tg mice compared to Wt mice (P < 0.01). As shown in Figure 4B and Table 2, hemodynamic assessment by cardiac catheterization revealed that LVDP, max dP/dt, and min dP/dt were significantly higher in HMGB1-Tg mice than in Wt mice (P < 0.05) at 4 weeks after MI. Furthermore, LVEDP was significantly lower (P < 0.01) and
Tau was significantly shorter (P < 0.05) in HMGB1-Tg mice compared to Wt mice at 4 weeks after MI. These data suggest that cardiac systolic and diastolic function at 4
weeks after MI was preserved in HMGB1-Tg mice compared to Wt mice.
HMGB1 improved survival rates after myocardial infarction
The survival rates from recovery of MI surgery were compared up to 4 weeks among Wt sham, HMGB1-Tg sham, Wt MI and HMGB1-TG MI groups ( Figure 5 ).
The survival rate up to 4 weeks after MI was significantly higher in HMGB1-Tg mice than in Wt mice (69% vs. 38%, P < 0.01).
Capillary and arteriole densities in the border zone
We HMGB1-deficient mice die within a few hours from birth, possibly as a result of a defect in activation of glucocorticoid receptor-responsive genes 26 .
The novel function of HMGB1 as a cytokine originates from studies of endotoxemia and sepsis 27 . HMGB1 acts as a late mediator of lipopolysaccharide (LPS) lethality. HMGB1 is released from a variety of cells including macrophages, pituicytes, peripheral blood mononuclear cells, and necrotic cells [4] [5] [6] [7] . Serum concentrations of HMGB1 increase significantly after administration of LPS or tumor necrosis factor-α in mice 27 . Effects of the extracellular HMGB1 are mediated by its 
Conclusions
We demonstrated the first in vivo evidence that HMGB1 enhances angiogenesis, restores cardiac function, and improves survival after myocardial infarction. These results may provide a novel potential strategy to prevent cardiac remodeling and improve cardiac function and survival for patients with ischemic disorders.
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